Search
Deciphera Pharmaceuticals, Inc.
  • About Us
    • Overview
    • Management
    • Board of Directors
    • Advisors
    • Funding and Support
    • Compliance
  • Our Pipeline
    • Overview
    • Our Medicine
    • Ripretinib (DCC-2618)
    • Rebastinib
    • DCC-3014
    • Expanded Access
  • Our Focus on Patients
    • Our Focus on Patients and Families
    • Gastrointestinal Stromal Tumors (GIST)
    • Breast Cancer
    • Tenosynovial Giant Cell Tumors (TGCT)
  • Our Research
    • Kinases in Cancer
    • Our Kinase Switch Control Platform
    • Presentations and Publications
  • Our Workplace
    • Our Culture and Values
    • Join Our Team
  • Investors
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Analyst Coverage
    • Press Releases
    • Deciphera in the News
    • Events and Presentations
    • Financial Information
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
  • Contact

Our Medicine
»
  • Overview
  • Our Medicine
  • Ripretinib (DCC-2618)
  • Rebastinib
  • DCC-3014
  • Expanded Access

NOW APPROVED

QINLOCK

For patients and healthcare providers in the United States, you can learn more about Qinlock™ (ripretinib) by visiting the product websites below or by accessing the prescribing information.

Patients
HCP

Letter to the GIST Patient Community

© 2021 Deciphera Pharmaceuticals, Inc. Deciphera, Deciphera Pharmaceuticals, and the Deciphera logo are trademarks of Deciphera Pharmaceuticals, LLC.
  • Terms of Use
  • Privacy Policy
  • Recruiting Privacy Policy
  • About Us
    • Overview
    • Management
    • Board of Directors
    • Advisors
    • Funding and Support
    • Compliance
  • Our Pipeline
    • Overview
    • Our Medicine
    • Ripretinib (DCC-2618)
    • Rebastinib
    • DCC-3014
    • Expanded Access
  • Our Focus on Patients
    • Our Focus on Patients and Families
    • Gastrointestinal Stromal Tumors (GIST)
    • Breast Cancer
    • Tenosynovial Giant Cell Tumors (TGCT)
  • Our Research
    • Kinases in Cancer
    • Our Kinase Switch Control Platform
    • Presentations and Publications
  • Our Workplace
    • Our Culture and Values
    • Join Our Team
  • Investors
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Analyst Coverage
    • Press Releases
    • Deciphera in the News
    • Events and Presentations
    • Financial Information
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
  • Contact